login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ARCTURUS THERAPEUTICS HOLDIN (ARCT) Stock News
NASDAQ:ARCT -
US03969T1097
-
Common Stock
17.01
USD
-0.29 (-1.68%)
Last: 8/29/2025, 6:10:02 PM
17.01
USD
0 (0%)
After Hours:
8/29/2025, 6:10:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARCT Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: Chartmill
- Mentions:
GEVO
KODK
TPIC
GDOT
...
Top movers in Tuesday's session
3 days ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Attend Upcoming Investor Conferences
15 days ago - By: Benzinga
- Mentions:
ELV
BIIB
INSM
XRAY
...
10 Health Care Stocks Whale Activity In Today's Session
16 days ago - By: Benzinga
- Mentions:
LIXT
DERM
EDIT
OVID
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
18 days ago - By: Zacks Investment Research
- Mentions:
IMTX
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
18 days ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
21 days ago - By: Zacks Investment Research
- Mentions:
CLSD
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
22 days ago - By: Zacks Investment Research
- Mentions:
INSM
Insmed (INSM) Reports Q2 Loss, Beats Revenue Estimates
24 days ago - By: Zacks Investment Research
- Mentions:
TNGX
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
a month ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
a month ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Attend Upcoming Investor Conferences
2 months ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
2 months ago - By: Arcturus Therapeutics
Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
3 months ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Attend Upcoming Investor Conferences
4 months ago - By: Yahoo Finance
- Mentions:
COIN
TTWO
UNH
DE
...
Take-Two Interactive Stock Slips After 'GTA 6' Maker's Outlook Comes Up Short
4 months ago - By: Yahoo Finance
- Mentions:
AMAT
WMT
ADCT
ENTA
...
AMAT Earnings: Demand Holding Up So Far
4 months ago - By: Yahoo Finance
- Mentions:
CAVA
TSHA
TTWO
AMAT
...
Cava: Rapid Growth but Some Concerns
4 months ago - By: Zacks Investment Research
Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade
4 months ago - By: Zacks Investment Research
- Mentions:
BOLT
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
4 months ago - By: Zacks Investment Research
- Mentions:
TECH
Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline
4 months ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
5 months ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARRĀ® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
6 months ago - By: Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
Please enable JavaScript to continue using this application.